Literature DB >> 8171015

Naturally processed heterodimeric disulfide-linked insulin peptides bind to major histocompatibility class II molecules on thymic epithelial cells.

F Forquet1, M Hadzija, J W Semple, E Speck, T L Delovitch.   

Abstract

We determined whether disulfide-linked insulin peptides that are immunogenic in vitro for CD4+ T cells bind to major histocompatibility complex class II in vivo. Radiolabeled recombinant human insulin (rHI) was injected into BALB/c mice, and processed rHI peptides bound to I-Ad molecules on different thymic antigen-presenting cells were characterized. The A6-A11/B7-B19 and A19-A21/B14-B21 disulfide-linked I-Ad-bound rHI peptides were isolated from thymic epithelial cells but not dendritic cells. While both thymic epithelial cells and dendritic cells present rHI to HI/I-Ad-specific T cells, these antigen-presenting cells do not present the reduced or nonreduced forms of the disulfide-linked rHI peptides. Thus, a naturally processed disulfide-linked peptide can bind to major histocompatibility complex class II in vivo. The potential role of these peptides in immunological tolerance is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8171015      PMCID: PMC43697          DOI: 10.1073/pnas.91.9.3936

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Phenotype of stromal cell-associated thymocytes in situ is compatible with selection of the T cell repertoire at an "immature" stage of thymic T cell differentiation.

Authors:  B A Kyewski; F Momburg; V Schirrmacher
Journal:  Eur J Immunol       Date:  1987-07       Impact factor: 5.532

2.  Processing and presentation of insulin. I. Analysis of immunogenic peptides and processing requirements for insulin A loop-specific T cells.

Authors:  P Naquet; J Ellis; B Singh; R S Hodges; T L Delovitch
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

3.  The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus.

Authors:  M Crowley; K Inaba; M Witmer-Pack; R M Steinman
Journal:  Cell Immunol       Date:  1989-01       Impact factor: 4.868

Review 4.  Treatment of autoimmune diseases by oral tolerance to autoantigens.

Authors:  H L Weiner
Journal:  Autoimmunity       Date:  1993       Impact factor: 2.815

5.  Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.

Authors:  D P Dialynas; Z S Quan; K A Wall; A Pierres; J Quintáns; M R Loken; M Pierres; F W Fitch
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

6.  Idiotypic analysis of anti-I-Ak monoclonal antibodies. I. Production and characterization of syngeneic anti-idiotypic mAb against an anti-I-Ak mAb.

Authors:  M L Phillips; J F Harris; T L Delovitch
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

7.  IA mutant functional antigen-presenting cell lines.

Authors:  L H Glimcher; T Hamano; R Asofsky; D H Sachs; M Pierres; L E Samelson; S O Sharrow; W E Paul
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

8.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

9.  T cell clones specific for an amphipathic alpha-helical region of sperm whale myoglobin show differing fine specificities for synthetic peptides. A multiview/single structure interpretation of immunodominance.

Authors:  K B Cease; I Berkower; J York-Jolley; J A Berzofsky
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

10.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

Authors:  J W Kappler; B Skidmore; J White; P Marrack
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  1 in total

1.  Antigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex molecules.

Authors:  M Bouvier; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.